SLC6A3 and Parkinson disease: These low affinity transporters could become more important in the clearance of monoamines when high-affinity transporters do not work normally (Hensler et al., 2013), such as in PD when dopaminergic neurons and DAT are significantly reduced, and levodopa-derived dopamine is excessively released in the extracellular space.